98 related articles for article (PubMed ID: 3733277)
1. Nifedipine serum concentrations following sublingual and oral doses.
Brown GR; Fraser DG; Castile JA; Gaudreault P; Platt DR; Friedman PA
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):283-6. PubMed ID: 3733277
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics and pharmacodynamics of verapamil in healthy volunteers after single oral and sublingual administration].
Woodcock BG; Wörner P; Rietbrock N; Schwabe L; Frömming KH
Arzneimittelforschung; 1982; 32(12):1567-71. PubMed ID: 6891597
[TBL] [Abstract][Full Text] [Related]
3. Alprazolam kinetics following sublingual and oral administration.
Scavone JM; Greenblatt DJ; Shader RI
J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
[TBL] [Abstract][Full Text] [Related]
4. Lormetazepam--plasma concentrations in volunteers following sublingual and oral dosing.
Luscombe DK
Psychopharmacology Suppl; 1984; 1():99-104. PubMed ID: 6147846
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol.
Aronsson A; Fiala C; Stephansson O; Granath F; Watzer B; Schweer H; Gemzell-Danielsson K
Hum Reprod; 2007 Jul; 22(7):1912-8. PubMed ID: 17488782
[TBL] [Abstract][Full Text] [Related]
6. The effect of sublingual nifedipine on coronary venous graft resistance immediately following cardiopulmonary bypass.
Eide TR; Katz RI; Poppers PJ
Anesth Analg; 1989 Apr; 68(4):462-6. PubMed ID: 2929979
[TBL] [Abstract][Full Text] [Related]
7. Sublingual nifedipine: the continuing controversy.
Oliver S
Aust Crit Care; 1994 Jun; 7(2):12-4. PubMed ID: 8061479
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic studies of nifedipine and digoxin co-administration.
Koren G; Zylber-Katz E; Granit L; Levy M
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):39-42. PubMed ID: 3957488
[TBL] [Abstract][Full Text] [Related]
9. Oral nifedipine pharmacokinetics in pregnancy-induced hypertension.
Prevost RR; Akl SA; Whybrew WD; Sibai BM
Pharmacotherapy; 1992; 12(3):174-7. PubMed ID: 1608848
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of flunitrazepam (Rohypnol) following oral and sublingual administration.
Hüttel MS; Bang U; Flachs H
Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):221-3. PubMed ID: 3710635
[TBL] [Abstract][Full Text] [Related]
11. [Central and peripheral hemodynamic effects of nifedipine administered orally and sublingually in essential arterial hypertension].
Levenson J; Simon AC; Bouthier JD; Maarek BC; Safar ME
Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():33-9. PubMed ID: 3937504
[TBL] [Abstract][Full Text] [Related]
12. Acute antihypertensive effect of nifedipine by sublingual route in cases with clinically severe systolic hypertension. A study up to 4 h after administration.
Ito H; Arakawa M; Shibasaki T; Hirakawa S; Fukuda T; Yasue T; Kondo Y; Watanabe I; Mori N; Fueki T
Arzneimittelforschung; 1984; 34(5):630-6. PubMed ID: 6380506
[TBL] [Abstract][Full Text] [Related]
13. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
Price TM; Blauer KL; Hansen M; Stanczyk F; Lobo R; Bates GW
Obstet Gynecol; 1997 Mar; 89(3):340-5. PubMed ID: 9052581
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
Al-Waili NS; Hasan NA
Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
[TBL] [Abstract][Full Text] [Related]
15. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of hypertensive crisis with sublingual nifedipine].
Tiberio G; Unzue JJ; Asín JL
Rev Clin Esp; 1985 Jul; 177(3):147. PubMed ID: 4059619
[No Abstract] [Full Text] [Related]
18. Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administration.
Castañeda-Hernández G; Hoyo-Vadillo C; Herrera JE
Int J Clin Pharmacol Ther; 1995 Jan; 33(1):56-60. PubMed ID: 7711994
[TBL] [Abstract][Full Text] [Related]
19. [Change in the diameter of the coronary vessels following sublingual or intravenous nifedipine administration correlated with the plasma level].
Nellessen U; Rafflenbeul W; Jost S; Daniel W; Hecker H; Lichtlen PR
Z Kardiol; 1987 Jun; 76(6):329-39. PubMed ID: 3630312
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of nicardipine following oral and intravenous administration in man.
Graham DJ; Dow RJ; Freedman D; Mroszczak E; Ling T
Postgrad Med J; 1984; 60 Suppl 4():7-10. PubMed ID: 6527979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
